News
The stock fell as much as 30% after it cut its guidance. The pharma giant named a new CEO in hopes of reviving growth., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback